肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2016 ESGE临床指南：食管支架置入治疗良恶性疾病

2016-09-14 欧洲胃肠道内窥镜学会 Endoscopy. 2016 Sep 14.

食管支架

2016年9月，欧洲胃肠道内窥镜学会(ESGE)发布了食管支架置入治疗良恶性疾病指南，食管支架置入经常用于治疗良性食管疾病，本文的目的是介绍了食管支架置入治疗良恶性食管肿瘤，并提出推荐意见。

中文标题：

2016 ESGE临床指南：食管支架置入治疗良恶性疾病

英文标题：

Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline.

发布机构：

欧洲胃肠道内窥镜学会

发布日期：

2016-09-14

简要介绍：

2016年9月，欧洲胃肠道内窥镜学会(ESGE)发布了食管支架置入治疗良恶性疾病指南，食管支架置入经常用于治疗良性食管疾病，本文的目的是介绍了食管支架置入治疗良恶性食管肿瘤，并提出推荐意见。

拓展指南：与食管支架相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 ESGE临床指南：食管支架置入治疗良恶性疾病)] GetToolGuiderByIdResponse(projectId=1, id=86da01c0012832b3, title=2016 ESGE临床指南：食管支架置入治疗良恶性疾病, enTitle=Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline., guiderFrom=Endoscopy. 2016 Sep 14., authorId=null, author=, summary=2016年9月，欧洲胃肠道内窥镜学会(ESGE)发布了食管支架置入治疗良恶性疾病指南，食管支架置入经常用于治疗良性食管疾病，本文的目的是介绍了食管支架置入治疗良恶性食管肿瘤，并提出推荐意见。, cover=, journalId=null, articlesId=null, associationId=434, associationName=欧洲胃肠道内窥镜学会, associationIntro=欧洲胃肠道内窥镜学会（ESGE，European Society of Gastrointestinal Endoscopy）致力于通过研讨会、出版指南、临床研究等发展先进的内窥镜技术。它代表了欧洲国际性内窥镜组织，地中海地区和北非团体均有加入的资格。, copyright=0, guiderPublishedTime=Wed Sep 14 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=2016年9月，欧洲胃肠道内窥镜学会(ESGE)发布了食管支架置入治疗良恶性疾病指南，食管支架置入经常用于治疗良性食管疾病，本文的目的是介绍了食管支架置入治疗良恶性食管肿瘤，并提出推荐意见。<br> <br> 拓展指南：<strong>与<font color=red>食管支架</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=86da01c0012832b3" title="2016 ESGE临床指南：食管支架置入治疗良恶性疾病" target=_blank>2016 ESGE临床指南：食管支架置入治疗良恶性疾病</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E9%A3%9F%E7%AE%A1%E6%94%AF%E6%9E%B6" target=_blank>有关食管支架更多指南</a></ul>, tagList=[TagDto(tagId=38301, tagName=食管支架)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3703, appHits=57, showAppHits=0, pcHits=2907, showPcHits=1020, likes=172, shares=0, comments=3, approvalStatus=1, publishedTime=Mon Sep 19 14:44:18 CST 2016, publishedTimeString=2016-09-14, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Mon Sep 19 14:44:18 CST 2016, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 17:11:09 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 ESGE临床指南：食管支架置入治疗良恶性疾病)])
2016 ESGE临床指南：食管支架置入治疗良恶性疾病
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=131221, encodeId=4ca41312216a, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f401615413, createdName=慧读, createdTime=Tue Sep 20 09:30:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131222, encodeId=a0b013122219, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f401615413, createdName=慧读, createdTime=Tue Sep 20 09:30:00 CST 2016, time=2016-09-20, status=1, ipAttribution=)]
    2016-09-20 慧读

    值得学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=131221, encodeId=4ca41312216a, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f401615413, createdName=慧读, createdTime=Tue Sep 20 09:30:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131222, encodeId=a0b013122219, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f401615413, createdName=慧读, createdTime=Tue Sep 20 09:30:00 CST 2016, time=2016-09-20, status=1, ipAttribution=)]
    2016-09-20 慧读

    继续关注

    0